Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Antinociceptive effect of co-administered NMDA and histamine H4 receptor antagonists in a rat model of acute pain.

Wolińska R, Leśniak A, Żochowska M, Sacharczuk M, Kieć-Kononowicz K, Bujalska-Zadrożny M.

Pharmacol Rep. 2017 Apr;69(2):222-228. doi: 10.1016/j.pharep.2016.10.018. Epub 2016 Oct 29.

PMID:
28092808
3.

Pleiotropic effect of histamine H4 receptor modulation in the central nervous system.

Galeotti N, Sanna MD, Ghelardini C.

Neuropharmacology. 2013 Aug;71:141-7. doi: 10.1016/j.neuropharm.2013.03.026. Epub 2013 Apr 11.

PMID:
23583928
4.

Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.

Hasanein P, Parviz M, Keshavarz M, Javanmardi K, Allahtavakoli M, Ghaseminejad M.

Eur J Pharmacol. 2007 Jan 12;554(2-3):123-7. Epub 2006 Oct 19.

PMID:
17107671
5.

Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats.

Luger TJ, Lorenz IH, Grabner-Weiss C, Hayashi T.

Br J Pharmacol. 1995 Mar;114(5):1097-103.

6.

Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.

Chizh BA, Reissmüller E, Schlütz H, Scheede M, Haase G, Englberger W.

Neuropharmacology. 2001;40(2):212-20.

PMID:
11114400
8.

Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.

Choi SS, Han EJ, Lee TH, Lee JK, Han KJ, Lee HK, Suh HW.

Planta Med. 2002 Sep;68(9):794-8.

PMID:
12357389
9.

Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity.

Deiteren A, De Man JG, Ruyssers NE, Moreels TG, Pelckmans PA, De Winter BY.

Gut. 2014 Dec;63(12):1873-82. doi: 10.1136/gutjnl-2013-305870. Epub 2014 Feb 21.

PMID:
24561612
11.
12.
14.

Aryl-1,3,5-triazine ligands of histamine H4 receptor attenuate inflammatory and nociceptive response to carrageen, zymosan and lipopolysaccharide.

Mogilski S, Kubacka M, Łażewska D, Więcek M, Głuch-Lutwin M, Tyszka-Czochara M, Bukowska-Strakova K, Filipek B, Kieć-Kononowicz K.

Inflamm Res. 2017 Jan;66(1):79-95. doi: 10.1007/s00011-016-0997-z. Epub 2016 Oct 20.

16.

Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.

Ehling S, Roßbach K, Dunston SM, Stark H, Bäumer W.

J Dermatol Sci. 2016 Aug;83(2):106-15. doi: 10.1016/j.jdermsci.2016.04.011. Epub 2016 Apr 22.

PMID:
27155791
17.

Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice.

Lutfy K, Cai SX, Woodward RM, Weber E.

Pain. 1997 Mar;70(1):31-40.

PMID:
9106807
18.

The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice.

Ohsawa Y, Hirasawa N.

Allergy. 2012 Aug;67(8):1014-22. doi: 10.1111/j.1398-9995.2012.02854.x. Epub 2012 Jun 12.

PMID:
22686688
19.

The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva.

Zampeli E, Thurmond RL, Tiligada E.

Inflamm Res. 2009 Jun;58(6):285-91. doi: 10.1007/s00011-009-8245-4.

PMID:
19184344
20.

Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.

Haghparast A, Gheitasi IP, Lashgari R.

Eur J Pain. 2007 Nov;11(8):855-62. Epub 2007 Feb 8.

PMID:
17291798

Supplemental Content

Support Center